These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 528225)

  • 1. Complement in cystic fibrosis.
    Strauss RG
    Helv Paediatr Acta; 1979; 34(5):429-35. PubMed ID: 528225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway of complement in sickle cell disease.
    Strauss RG; Asbrock T; Forristal J; West CD
    Pediatr Res; 1977 Apr; 11(4):285-9. PubMed ID: 846782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The septic burned patient: a model for studying the role of complement and immunoglobulins in opsonization of opportunist micro-organisms.
    Bjornson AB; Altemeier WA; Bjornson HS
    Ann Surg; 1979 Apr; 189(4):515-27. PubMed ID: 109057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement abnormalities during an epidemic of group B meningococcal infection in children.
    Beatty DW; Ryder CR; Heese HD
    Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections.
    Otesile EB; Lee M; Tabel H
    J Parasitol; 1991 Dec; 77(6):958-64. PubMed ID: 1838113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the alternative complement pathway in patients with amebic liver abscess].
    Capin MR; Jiménez M; Zamacona G; Ortíz-Ortíz L
    Arch Invest Med (Mex); 1978; 9 Suppl 1():297-302. PubMed ID: 697476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of complement by gold sodium thiomalate.
    Hasselbacher P
    J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients.
    Bjornson AB; Altemeier WA; Bjornson HS; Tang T; Iserson ML
    Ann Surg; 1978 Jul; 188(1):93-101. PubMed ID: 666383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
    Nakanishi K; Zbar B; Borsos T; Glenn G
    Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.